跳至主要内容
临床试验/NCT06056141
NCT06056141已完成4 期

Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter: a Multicentre Randomised Controlled Trial

Kazakhstan's Medical University "KSPH"2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300
试验地点
2
主要终点
Efficiency of induction

研究概览

简要总结

Comparison of efficacy and safety of low-dose oral Misoprostol versus folley catheter for preinduction in women with an immature cervix at term.

详细描述

Open-label randomised trial in 2 hospitals in the Almaty,Kazakhstan. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section will be randomly allocated to 2 groups: 1 group -cervical ripening with 25 μg oral misoprostol once every 2 hour, 2 nd group- a 30 mL transcervical Foley catheter. The primary outcome will be vaginal delivery within 24 hours(to evaluate effectiveness) and secondary outcoms 1-5-min Apgar score and hospitalization in ICU, hyperstimulation frequency and hemorrage (for evaluating safety)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with an unfavourable cervix who will scheduled for induction of labour

排除标准

  • Women with previous caesarean sections unable to give informed consent Multiple pregnancy History of allergy to misoprostol Ruptured membranes Chorioamnionitis All cases when physiological childbirth is impossible (placenta previa,transverse position of the fetus )

研究组 & 干预措施

Group A

Active Comparator

Drug: Misoprostol 25mcg (200 mcg dissolved with 200 ml water and divided to 8 doses) every 2 hours

干预措施: Misoprostol 200mcg Tab (Drug)

Group B

Active Comparator

Device: Foley Catheter Transcervical Foley catheter (silicone, size 20F with 30ml balloon)

干预措施: Foley Catheter (Device)

结局指标

主要结局

Efficiency of induction

时间窗: 24 hours.

Number of Participants with vaginal births within 24 hours.

次要结局

  • Safety for mother(during the labour induction)
  • Safety for baby(5 min)

研究者

发起方
Kazakhstan's Medical University "KSPH"
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dilfuza Sultanmuratova

principal investigator

Kazakhstan's Medical University "KSPH"

研究点 (2)

Loading locations...

相似试验

Induction of Labour at Term With Low Dose Oral... | 临床试验